These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6343337)

  • 1. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
    Miller MA; Finan M; Yousuf M
    J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE; Del Bene VE; Collins CD
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
    Vuye A
    Chemotherapy; 1982; 28(4):267-75. PubMed ID: 6981493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
    Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
    Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
    Chau PY; Ling J; Ng WS
    J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.
    Bakken JS; Sanders CC; Clark RB; Hori M
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1314-9. PubMed ID: 3264129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative stability of first, second and third generation cephalosporins and N-formimidoyl thienamycin against gram-negative beta-lactamases.
    Vuye A
    Arzneimittelforschung; 1983; 33(9):1236-9. PubMed ID: 6605753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K; Tarbuc R
    Infection; 1982; 10(6):361-70. PubMed ID: 6818153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial antagonism of beta-lactam antibiotics in experimental infections.
    Kasai K
    Chemotherapy; 1986; 32(2):148-58. PubMed ID: 3516593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.
    Papanicolaou GA; Medeiros AA
    Diagn Microbiol Infect Dis; 1991; 14(1):85-7. PubMed ID: 2013214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    Pusztai-Markos Z; Pranada F
    Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antagonism of beta-lactam antibiotics by cefoxitin.
    Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1982 Jun; 21(6):968-75. PubMed ID: 6981376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of N-formimidoyl thienamycin (MK 0787) compared with other beta-lactamase stable cephalosporins against beta-lactamase producing Staphylococcus aureus.
    Ray B; Panja K; Bal M
    Indian J Med Res; 1984 Apr; 79():482-6. PubMed ID: 6333393
    [No Abstract]   [Full Text] [Related]  

  • 17. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
    Hechler U; van den Weghe M; Martin HH; Frère JM
    J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1079-81. PubMed ID: 6961887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Corrado ML; Landesman SH; Cherubin CE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.